Sanofi-Regeneron's Praluent cuts cholesterol in Odyssey trials
reutersCOMPANYNEWS companyNews
PARIS, June 11 (Reuters) - France's Sanofi and
partner Regeneron Pharmaceuticals said on Sunday their
anti-cholesterol drug Praluent recorded positive results in its
first dedicated studies involving patients with diabetes and
high cholesterol.
← Older Post Newer Post →